{"altmetric_id":1780830,"counts":{"readers":{"mendeley":9,"citeulike":0,"connotea":0},"total":{"posts_count":6},"twitter":{"unique_users_count":5,"unique_users":["CRWLibrary","mlazqui","drlison","sogug1","GoToPER"],"posts_count":6}},"selected_quotes":["orafenib plus interleukin-2 compared with sorafenib alone in metastatic renal cell carcinoma: ROSOTC trial","Overall survival for sorafenib + interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma (mRCC)"],"citation":{"abstract":"The ROSORC trial, a randomised, phase II trial comparing sorafenib plus interleukin (IL-2) versus sorafenib alone as first-line treatment of metastatic renal cell carcinoma (mRCC) failed to demonstrate differences in progression-free survival (PFS). Updated overall survival (OS) results are reported.","abstract_source":"pubmed","altmetric_jid":"4f6fa4e83cf058f610002280","authors":["E. Bajetta"],"doi":"10.1093\/annonc\/mdt375","first_seen_on":"2013-09-25T06:02:33+00:00","issns":["1569-8041"],"journal":"Annals of Oncology","last_mentioned_on":1385487815,"links":["http:\/\/annonc.oxfordjournals.org\/content\/early\/2013\/09\/23\/annonc.mdt375.short?rss=1","http:\/\/annonc.oxfordjournals.org\/content\/early\/2013\/09\/23\/annonc.mdt375.abstract","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24063860?dopt=Abstract","http:\/\/annonc.oxfordjournals.org\/content\/24\/12\/2967.short?rss=1"],"pdf_url":"http:\/\/annonc.oxfordjournals.org\/content\/early\/2013\/09\/23\/annonc.mdt375.full.pdf","pmid":"24063860","pubdate":"2013-01-01T00:00:00+00:00","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["neoplasms"],"title":"Overall survival for sorafenib plus interleukin-2 compared with sorafenib alone in metastatic renal cell carcinoma (mRCC): final results of the ROSORC trial","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/overall-survival-sorafenib-plus-interleukin2-compared-sorafenib-alone-metastatic-renal-cell-carcinom"},"altmetric_score":{"score":2.5,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":2.5},"context_for_score":{"all":{"total_number_of_other_articles":4508238,"mean":5.1674528195662,"rank":1650681,"this_scored_higher_than_pct":62,"this_scored_higher_than":2825172,"rank_type":"exact","sample_size":4508238,"percentile":62},"similar_age_3m":{"total_number_of_other_articles":98189,"mean":7.8415232411295,"rank":31217,"this_scored_higher_than_pct":67,"this_scored_higher_than":66224,"rank_type":"exact","sample_size":98189,"percentile":67},"this_journal":{"total_number_of_other_articles":2299,"mean":5.0232680591819,"rank":922,"this_scored_higher_than_pct":58,"this_scored_higher_than":1353,"rank_type":"exact","sample_size":2299,"percentile":58},"similar_age_this_journal_3m":{"total_number_of_other_articles":67,"mean":3.7018181818182,"rank":21,"this_scored_higher_than_pct":67,"this_scored_higher_than":45,"rank_type":"exact","sample_size":67,"percentile":67}}},"demographics":{"poster_types":{"member_of_the_public":3,"practitioner":2},"users":{"twitter":{"cohorts":{"Practitioners (doctors, other healthcare professionals)":3,"Members of the public":2}},"mendeley":{"by_status":{"Researcher":1,"Student  > Ph. D. Student":2,"Other":3,"Student  > Master":1,"Student  > Bachelor":2},"by_discipline":{"Medicine and Dentistry":6,"Computer Science":1,"Biochemistry, Genetics and Molecular Biology":1,"Unspecified":1}}},"geo":{"twitter":{"GB":1,"ES":1,"US":1},"mendeley":{"GB":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/CRWLibrary\/status\/383507538357932032","license":"public","citation_ids":[1780830],"posted_on":"2013-09-27T08:24:57+00:00","author":{"name":"Cancer Library VCC","url":"http:\/\/www.wales.nhs.uk\/velindrelibrary","image":"https:\/\/pbs.twimg.com\/profile_images\/478464349476884480\/YlBsicot_normal.jpeg","description":"The only cancer specialist library service in Wales.  Supporting NHS and academic staff, students and health professionals throughout the Principality.","id_on_source":"CRWLibrary","tweeter_id":"1288296943","geo":{"lt":51.48,"ln":-3.18,"country":"GB"},"followers":650},"tweet_id":"383507538357932032"},{"url":"http:\/\/twitter.com\/mlazqui\/status\/382746617537110016","license":"public","citation_ids":[1780830],"posted_on":"2013-09-25T06:01:19+00:00","author":{"name":"Mart\u00edn L\u00e1zaro","url":"http:\/\/www.novedadesenoncologia.blogspot.com","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000653691864\/11d6fb0c77217bfce2c907aa9b0f2ee5_normal.jpeg","description":"Medical oncologist. Lung and genitourinary cancer.","id_on_source":"mlazqui","tweeter_id":"196132848","geo":{"lt":42.23282,"ln":-8.72264,"country":"ES"},"followers":1703},"tweet_id":"382746617537110016"},{"url":"http:\/\/twitter.com\/drlison\/status\/382746962325684224","license":"public","rt":["mlazqui"],"citation_ids":[1780830],"posted_on":"2013-09-25T06:02:41+00:00","author":{"name":"LuisC Fern\u00e1ndezLis\u00f3n","url":"http:\/\/imaginefarma.blogspot.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/620555227482222592\/4u9TmOro_normal.jpg","description":"Doctor. Jefe de Secci\u00f3n de Farmacia Hospitalaria. Complejo Hospitalario Universitario de C\u00e1ceres. M\u00fasico amateur. Ut\u00f3pico profesional.","id_on_source":"drlison","tweeter_id":"139429992","geo":{"lt":null,"ln":null},"followers":4605},"tweet_id":"382746962325684224"},{"url":"http:\/\/twitter.com\/mlazqui\/status\/405389867963932672","license":"public","citation_ids":[1780830],"posted_on":"2013-11-26T17:37:30+00:00","author":{"name":"Mart\u00edn L\u00e1zaro","url":"http:\/\/www.novedadesenoncologia.blogspot.com","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000653691864\/11d6fb0c77217bfce2c907aa9b0f2ee5_normal.jpeg","description":"Medical oncologist. Lung and genitourinary cancer.","id_on_source":"mlazqui","tweeter_id":"196132848","geo":{"lt":42.23282,"ln":-8.72264,"country":"ES"},"followers":1703},"tweet_id":"405389867963932672"},{"url":"http:\/\/twitter.com\/sogug1\/status\/405391398566133760","license":"public","citation_ids":[1780830],"posted_on":"2013-11-26T17:43:35+00:00","author":{"name":"SOGUG","image":"https:\/\/pbs.twimg.com\/profile_images\/777058730982662144\/hUowGuNg_normal.jpg","description":"Cuenta oficial del Grupo Espa\u00f1ol de Tumores Genitourinarios \/ Spanish Oncology Genitourinary Group's official account","id_on_source":"sogug1","tweeter_id":"1136854537","geo":{"lt":null,"ln":null},"followers":863},"tweet_id":"405391398566133760"},{"url":"http:\/\/twitter.com\/GoToPER\/status\/388870466523254784","license":"public","citation_ids":[1780830],"posted_on":"2013-10-12T03:35:18+00:00","author":{"name":"PER","url":"http:\/\/gotoper.com","image":"https:\/\/pbs.twimg.com\/profile_images\/3438723869\/2416df847bccb4c5ad8da6015ba30370_normal.jpeg","description":"Physicians' Education Resource (PER) specializes in oncology and hematology CME-certified activities. We advance cancer care through professional education.","id_on_source":"GoToPER","tweeter_id":"37703552","geo":{"lt":40.31622,"ln":-74.51376,"country":"US"},"followers":4420},"tweet_id":"388870466523254784"}]}}